Bright Minds Biosciences (NASDAQ:DRUG) entered into an equity distribution agreement providing for an at-the-market equity offering program with Piper Sandler & Co. and Cantor Fitzgerald & Co.
The ATM will allow Bright Minds, through the agents, to offer and sell from